Associations of SHR with all-cause mortality. by Heshan Cao (17967095)

Subjects:

Identification test and cause analysis. by Wei Wang (17594)

Identification test and cause analysis. by Wei Wang (17594)

The hazard ratios of pleural effusion with all-cause and cause-specific death (refer to non-pleural effusion). by Fengping Zhang (8355645)

Rates for the composite EP consisted of all-cause mortality, stroke, major bleedings and MI increased as eGFR declined. by Christian Salbach (10170370)

HRs for all-cause mortality in different subgroups in the original cohort. by Sheng Chen (21971)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

A possible cause of epistaxis: increased masked hypertension prevalence in patients with epistaxis by Baran Acar (10419356)

“…Conclusion This study demonstrates increased masked hypertension prevalence in patients with epistaxis. …”

Proportion of ACSC by groups of causes, considering the five most frequent causes. by Isabelle Aguiar Prado (12850436)

Details of the damage caused by large-scale earthquakes. by Yuta Inoue (2404879)

HR (95% CI) of all-cause mortality and cause specific mortality according to vitamin D status. by Yan Wang (15435)

Subjects:

Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

Drosophila homologs of mammalian ATF4 target genes with significantly increased expression in ND-75^KD flies. by Lucy Granat (5570813)

Association of SHR and the risk of all-cause mortality. by Heshan Cao (17967095)

Subjects:

Table1_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”

Table2_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”

Data_Sheet_1_Physiological synchrony in electrodermal activity predicts decreased vigilant attention induced by sleep deprivation.docx by Ivo V. Stuldreher (11897870)

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly increased expression... by Lucy Granat (5570813)